EFFECTIVENESS OF NEUROBIC EXERCISE PROGRAM ON MEMORY PERFORMANCE IN COMMUNITY-DWELLING OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT: A RANDOMIZED CONTROLLED CROSSOVER TRIA

Phase 2

• Conditions: Many older people complain of impaired memory and do less well than the young in various cognitive tasks, particularly those relevant to memory. About one in ten people aged 65 years old has dementia, and the prevalence increases by age. The effects of mild cognitive impairment in older adults can negatively impact both the individuals themselves as well as the other people surrounding them.; NEUROBIC EXERCISE; MEMORY PERFORMANCE; MILD COGNITIVE IMPAIRMENT; OLDER ADULTS; CROSSOVER TRIAL

• Registration Number: TCTR20210326003
• Lead Sponsor: BURAPHA UNIVERSITY

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-26
• Study Completion: 2021-12-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

1. Males and females aged 60 years or older who have MCI as screened by using the Montreal Cognitive Assessment (MoCA); persons with scores less than 24 are considered as having MCI.
2. Being independent as screened by using Modified Barthel ADL index (BAI); BAI score should be at least 12 which indicates independence.
3. Body Mass Index (BMI) score range 18.49-35.00 kg/m2 According to Obesity Indices for Thais (Mookdadilok, 2012), this value is used to indicate no malnutrition and obesity for Thai people.
4. No history of psychiatric disorder or neurological condition (e.g., epilepsy, stroke, dementia, head injury, depression, etc.)
5. No hearing or visual impairment as diagnosed by a physician.
6. Ability to write and read as well as communicate well.
7. Willingness to participate in the study throughout the program.

Exclusion Criteria

The participants who have severe complications or serious neurological or musculoskeletal conditions and serious conditions from comorbidity (e.g., diabetes mellitus, hypertension, stroke, cardiovascular disease, etc.), which make them unable to participate in the intervention, and older adults with a history of food or flower allergies that used in activities, will be excluded. Moreover, participants who do not participate in all sessions of intervention will also be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Memory performance Four measured periods at the baseline, week 3, week 7, and week 9 The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) score and The Common Objects Memory Test (COMT) score

Secondary Outcome Measures

Name	Time	Method
Cognitive impairment week 9 The Montreal Cognitive Assessment score